Gentherm authorizes new $400M share repurchase program
Thermal management leader replaces prior program effective July 27, 2026; three-year authorization reflects confidence in cash generation
What the filing says
Gentherm Inc. announced that its Board of Directors authorized a new stock repurchase program of up to $400 million of the company's issued and outstanding common stock, as disclosed in an 8-K filing on July 23, 2026. The new program will replace the company's existing stock repurchase program effective July 27, 2026, and will remain in effect for a three-year period. As of June 30, 2026, the prior program had approximately $110 million of stock repurchase authorization remaining.
The authorization comes as Gentherm reported strong second-quarter 2026 financial results, including record quarterly product revenues of $416.2 million, a 9.5% increase excluding foreign currency translation. The company also raised its full-year 2026 guidance, citing strong commercial performance and execution on operating systems and key performance indicators.
According to Chief Financial Officer Jon Douyard, the new authorization reflects the company's confidence in its long-term cash flow generation. "With a strong balance sheet and access to capital, we are well positioned to execute our strategic priorities while maintaining a disciplined approach to capital allocation," Douyard stated in the filing. The company reported net leverage of approximately 0.3x and liquidity of $502.3 million as of the quarter-end.
The execution mechanism and timing of any repurchases under the new program are not specified in the filing.
The Board of Directors authorized a new stock repurchase program of up to $400 million of the Company's issued and outstanding common stock. The new program will replace the Company's existing stock repurchase program effective July 27, 2026, and will remain in effect for a three-year period. — Gentherm Inc 8-K filing · View on SEC EDGAR →
What this means
Gentherm's new $400 million authorization represents a modest increase from the $110 million remaining under the prior program, bringing total available capacity to $510 million combined (though the old program will be replaced). With approximately 30.7 million shares outstanding and a strong balance sheet (0.3x net leverage), the authorization suggests management confidence in cash generation and capital returns. The three-year window provides flexibility for execution during varying market conditions without pressuring near-term liquidity, which currently stands at $502 million.
Frequently asked questions
- What triggers the replacement of Gentherm's prior buyback program?
- The new $400 million authorization becomes effective on July 27, 2026, and replaces the existing program on that date. The prior program had $110 million remaining as of June 30, 2026. The transition is automatic and designed to provide a fresh authorization framework with a new three-year term.
- How does this authorization support shareholder returns amid the pending Modine merger?
- Gentherm notes in the filing that it remains on track to close the planned combination with Modine Performance Technologies by early Q4 2026. The new buyback authorization demonstrates near-term capital allocation flexibility, though any material repurchases would likely be evaluated in light of merger completion timing and integration priorities.
- What is the company's current financial position relative to this buyback capacity?
- Gentherm reported net leverage of 0.3x, total liquidity of $502.3 million, and record Q2 2026 revenue of $416.2 million (up 9.5% ex-FX). Management raised full-year guidance for product revenues, adjusted EBITDA, and free cash flow, suggesting strong operational momentum and capacity to execute capital returns.
- How many shares might this $400M authorization repurchase?
- The filing does not specify an execution mechanism, share count, or average price assumption. With approximately 30.7 million shares outstanding as of June 30, 2026, the authorization would represent roughly 1–2% of current shares depending on execution price and market conditions over the three-year term.
- What does the three-year term mean for execution timing?
- A three-year authorization window provides management flexibility to execute repurchases opportunistically without a compressed timeline. The company is not obligated to spend the full $400 million and can adjust pace based on cash generation, merger integration demands, and capital needs.
- Will the prior $110M remaining authorization expire unused?
- Yes. The prior program's remaining $110 million authorization will be replaced and rendered inactive on July 27, 2026. Any repurchases going forward will be executed under the new $400 million program.